Allianz Asset Management Gmb H Teva Pharmaceutical Industries LTD Transaction History

Allianz Asset Management Gmb H

$65.6 Billion
Q2 2024

A detailed history of Allianz Asset Management Gmb H transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 610,195 shares of TEVA stock, worth $10.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

610,195

Previous 1,352,565 54.89%

Holding current value

$10.9 Million

Previous $19.1 Million 48.05%

% of portfolio

0.02%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$12.78 - $17.4 $9.49 Million - $12.9 Million	-742,370 Reduced 54.89%	610,195 $9.92 Million
Q1 2024 May 13, 2024	SELL	$10.67 - $14.43 $8.01 Million - $10.8 Million	-750,249 Reduced 35.68%	1,352,565 $19.1 Million
Q4 2023 Feb 12, 2024	SELL	$8.12 - $10.63 $6.45 Million - $8.45 Million	-794,934 Reduced 27.43%	2,102,814 $22 Million
Q3 2023 Nov 13, 2023	SELL	$7.48 - $10.7 $1.13 Million - $1.62 Million	-151,721 Reduced 4.98%	2,897,748 $29.6 Million
Q2 2023 Aug 11, 2023	SELL	$7.2 - $9.47 $989,172 - $1.3 Million	-137,385 Reduced 4.31%	3,049,469 $23 Million
Q1 2023 May 11, 2023	BUY	$8.36 - $11.37 $4.98 Million - $6.77 Million	595,548 Added 22.98%	3,186,854 $28.2 Million
Q4 2022 Feb 13, 2023	BUY	$7.95 - $9.48 $3.81 Million - $4.54 Million	478,741 Added 22.66%	2,591,306 $23.6 Million
Q3 2022 Nov 08, 2022	BUY	$6.86 - $11.95 $2.56 Million - $4.46 Million	373,402 Added 21.47%	2,112,565 $17 Million
Q2 2022 Aug 12, 2022	BUY	$7.38 - $10.4 $382,365 - $538,834	51,811 Added 3.07%	1,739,163 $13.1 Million
Q1 2022 May 13, 2022	BUY	$7.33 - $9.39 $12.4 Million - $15.8 Million	1,687,352 New	1,687,352 $15.8 Million
Q2 2021 Aug 16, 2021	SELL	$9.9 - $11.56 $6.07 Million - $7.09 Million	-613,127 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$10.34 - $12.81 $15.6 Million - $19.3 Million	-1,506,839 Reduced 71.08%	613,127 $7.08 Million
Q4 2020 Feb 16, 2021	BUY	$8.61 - $11.04 $66,555 - $85,339	7,730 Added 0.37%	2,119,966 $20.5 Million
Q3 2020 Nov 13, 2020	SELL	$8.57 - $12.69 $3.59 Million - $5.32 Million	-419,138 Reduced 16.56%	2,112,236 $19 Million
Q2 2020 Aug 14, 2020	BUY	$8.12 - $13.12 $2.48 Million - $4.01 Million	305,830 Added 13.74%	2,531,374 $31.2 Million
Q1 2020 May 14, 2020	BUY	$6.69 - $13.45 $1.64 Million - $3.3 Million	245,022 Added 12.37%	2,225,544 $20 Million
Q4 2019 Feb 13, 2020	SELL	$6.53 - $10.72 $149,778 - $245,884	-22,937 Reduced 1.14%	1,980,522 $19.4 Million
Q3 2019 Nov 13, 2019	SELL	$6.16 - $9.6 $291,866 - $454,857	-47,381 Reduced 2.31%	2,003,459 $13.8 Million
Q2 2019 Aug 08, 2019	BUY	$8.12 - $15.72 $149,643 - $289,703	18,429 Added 0.91%	2,050,840 $18.9 Million
Q1 2019 May 13, 2019	SELL	$15.58 - $20.01 $2.09 Million - $2.68 Million	-134,167 Reduced 6.19%	2,032,411 $31.9 Million
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $31.6 Million - $51.7 Million	2,166,578 New	2,166,578 $33.4 Million
Q2 2018 Aug 13, 2018	SELL	$16.77 - $24.71 $2.88 Million - $4.24 Million	-171,697 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$16.68 - $22.07 $333,600 - $441,400	-20,000 Reduced 10.43%	171,697 $2.93 Million
Q4 2017 Feb 13, 2018	SELL	$11.23 - $19.1 $3.67 Million - $6.24 Million	-326,867 Reduced 63.03%	191,697 $3.63 Million
Q3 2017 Nov 13, 2017	BUY	$15.41 - $32.17 $708,829 - $1.48 Million	45,998 Added 9.73%	518,564 $9.13 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-680,996 Reduced 59.03%	472,566 $15.6 Million
Q1 2017 Apr 17, 2019	SELL	N/A	-469,173 Reduced 28.91%	1,153,562 $37 Million
Q4 2016 Apr 17, 2019	BUY	N/A	5,659 Added 0.35%	1,622,735 $58.8 Million
Q3 2016 Apr 17, 2019	BUY	N/A	1,617,076	1,617,076 $74.5 Million

Others Institutions Holding TEVA

# of Institutions

603

Shares Held

567M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Teva Pharmaceutical Industries LTD Transaction History